Compare PRME & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRME | MBUU |
|---|---|---|
| Founded | 2019 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.4M | 541.4M |
| IPO Year | 2022 | 2013 |
| Metric | PRME | MBUU |
|---|---|---|
| Price | $3.07 | $28.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | $7.56 | ★ $32.20 |
| AVG Volume (30 Days) | ★ 4.4M | 302.1K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.18 | ★ 127.74 |
| EPS | ★ N/A | N/A |
| Revenue | $4,632,000.00 | ★ $807,561,000.00 |
| Revenue This Year | $7.06 | $2.14 |
| Revenue Next Year | $47.01 | $12.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 55.28 | N/A |
| 52 Week Low | $2.67 | $23.84 |
| 52 Week High | $6.94 | $39.65 |
| Indicator | PRME | MBUU |
|---|---|---|
| Relative Strength Index (RSI) | 41.07 | 55.83 |
| Support Level | $2.68 | $28.10 |
| Resistance Level | $3.82 | $29.57 |
| Average True Range (ATR) | 0.32 | 1.29 |
| MACD | -0.11 | 0.24 |
| Stochastic Oscillator | 0.57 | 73.33 |
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Most recently, in 2026, it tied up with Saxdor Yachts, focused on adventure dayboats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.